Camp4 Therapeutics (CAMP) Change in Account Payables (2023 - 2026)

Camp4 Therapeutics has reported Change in Account Payables for 4 years, with the latest figure at $592000.0 in Q1 2026.

• Quarterly Change in Account Payables rose 238.29% year-over-year to $592000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$611000.0 (up 4.83% YoY) and the FY2025 annual result came in at -$1.0 million, down 711.9% from the prior year.
• Change in Account Payables improved to $592000.0 in Q1 2026 per CAMP's latest filing, from -$467000.0 in the prior quarter.
• Over five years, Change in Account Payables peaked at $1.1 million in Q3 2024 and troughed at -$1.0 million in Q2 2024.
• A 4-year average of -$41800.0 and a median of -$170000.0 in 2023 frame the typical range for Change in Account Payables.
• The sharpest annual moves came in 2024 and 2026: Change in Account Payables tumbled 470.67% in 2024, then surged 238.29% in 2026.
• Over 4 years, Change in Account Payables stood at -$150000.0 in 2023, then sank by 470.67% to -$856000.0 in 2024, then surged by 45.44% to -$467000.0 in 2025, then surged by 226.77% to $592000.0 in 2026.
• According to Business Quant data, Change in Account Payables over the past three periods registered $592000.0, -$467000.0, and -$546000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.